Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Oncbiomune Pharmaceuticals Inc (OBMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0089 +15.73%
on 01/18/19
0.0140 -26.43%
on 12/24/18
-0.0016 (-13.45%)
since 12/21/18
3-Month
0.0089 +15.73%
on 01/18/19
0.0240 -57.08%
on 11/08/18
-0.0089 (-46.35%)
since 10/22/18
52-Week
0.0089 +15.73%
on 01/18/19
0.0450 -77.11%
on 06/04/18
-0.0197 (-65.67%)
since 01/22/18

Most Recent Stories

More News
OncBioMune Announces Former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary therapeutic cancer vaccine immunotherapy...

OBMP : 0.0103 (-6.36%)
PBYI : 23.68 (-6.11%)
PIMCO Closed-End Funds Declare Special Year-End Distribution

The Board of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds") has declared a special year-end distribution for certain Fund's common shares as summarized...

IPG : 21.65 (-2.70%)
NGVC : 15.75 (-2.42%)
STC : 43.17 (-0.99%)
ATUS : 18.73 (-1.78%)
RBA : 36.28 (+0.08%)
MHK : 126.72 (+0.08%)
NVCR : 46.62 (+0.37%)
CVSI : 4.6600 (+6.39%)
AC : 39.07 (-3.82%)
BSX : 37.26 (-1.14%)
HON : 139.82 (-1.43%)
POTND : 0.0200 (+32.45%)
PRTT : 1.2500 (-30.56%)
TARSD : 0.2033 (-1.64%)
NKE : 80.75 (+0.37%)
ROIC : 16.78 (-0.59%)
DGX : 86.18 (-0.99%)
EIX : 54.21 (-1.22%)
GARLF : 0.0850 (-2.19%)
MRNA : 15.56 (-6.77%)
MSPC : 0.0002 (unch)
RYAAY : 69.09 (+5.08%)
BA : 357.90 (-1.87%)
BDC : 50.92 (-3.69%)
BC : 48.99 (-2.68%)
OXFD : 14.46 (-2.82%)
NDAQ : 83.40 (+0.31%)
TTOO : 3.60 (-0.28%)
DMAC : 3.60 (-1.10%)
CMCM : 6.50 (-0.76%)
ALGN : 216.16 (-1.79%)
ABM : 35.23 (-2.08%)
RTN : 163.71 (-1.03%)
IESC : 17.02 (+0.71%)
KIDS : 34.06 (+0.06%)
CYL.VN : 0.175 (+12.90%)
FLIR : 44.73 (-1.45%)
NETC.CN : 0.140 (+7.69%)
SLCA : 13.36 (-3.95%)
BANX : 19.85 (+0.61%)
APOG : 33.82 (-1.26%)
RBBN : 5.53 (-2.47%)
SPLIF : 0.2100 (-0.43%)
SO : 47.07 (-0.32%)
SNWV : 0.2170 (-9.01%)
ACB : 6.19 (-3.88%)
CE : 95.73 (-2.13%)
QILFF : 0.1900 (-4.62%)
QILFD : 0.2331 (-29.98%)
MANH : 47.82 (-1.14%)
MKL : 1,035.00 (-3.11%)
HAL : 31.26 (-3.07%)
LZB : 29.68 (-1.49%)
INTC : 48.27 (-1.87%)
APHQF : 11.5700 (-3.05%)
AMZN : 1,632.17 (-3.77%)
ACHC : 28.32 (-2.31%)
TX : 28.26 (-2.18%)
SRPT : 120.28 (-2.05%)
JOUT : 63.52 (-4.95%)
CCAN : 0.2650 (+10.42%)
OBMP : 0.0103 (-6.36%)
ELY : 16.51 (-2.77%)
DY : 57.47 (-3.14%)
HIPH : 0.0530 (-5.19%)
POTN : 0.1058 (-0.94%)
JWN : 47.07 (-0.95%)
SYF : 26.55 (+1.03%)
AQUA : 10.04 (-4.02%)
NWVCF : 1.0517 (+0.16%)
USYNF : 3.1500 (+5.77%)
EMR : 63.01 (-1.05%)
BXE : 0.43 (-2.27%)
HSY : 108.31 (+0.16%)
EW : 168.29 (-0.07%)
SCQBD : 0.7420 (+1.08%)
PTS.TO : 13.11 (+0.15%)
PSX : 93.00 (-2.41%)
MVIS : 0.79 (-1.86%)
PCI : 22.27 (-1.63%)
PCN : 15.42 (+0.72%)
AVT : 41.25 (-2.92%)
MGNX : 11.53 (-6.34%)
ICBK : 18.21 (-4.26%)
DLR : 105.10 (-2.00%)
RHI : 59.76 (-1.82%)
YVR : 2.37 (-1.66%)
PTY : 16.08 (+0.63%)
PDI : 31.12 (-1.27%)
TNXP : 1.93 (-6.31%)
GBT : 47.82 (-2.15%)
QI.VN : 0.290 (-27.50%)
TSRO : 74.96 (+0.03%)
RHP : 76.42 (-0.31%)
NKTR : 44.76 (-3.12%)
GOOG : 1,070.52 (-2.53%)
JBLU : 17.37 (-1.31%)
IGC : 2.49 (unch)
WBT : 13.21 (-0.53%)
WRY.VN : 0.045 (+800.00%)
SAPIF : 28.6410 (-1.69%)
WSO : 144.38 (-0.99%)
LMT : 279.59 (-1.16%)
CMCSA : 34.97 (-3.42%)
HSDT : 7.65 (-8.16%)
GWRE : 84.94 (-0.90%)
CLGX : 36.05 (-1.39%)
FNSR : 21.21 (-2.35%)
SONS : 7.83 (+2.76%)
DEWM : 0.0010 (-9.09%)
SLG : 88.34 (-1.01%)
UPS : 102.68 (+1.06%)
PFN : 9.82 (+0.10%)
KMB : 115.23 (-1.40%)
ANZ.VN : 0.075 (+7.14%)
TAOP : 1.14 (-5.00%)
NSU : 4.48 (-0.88%)
CBDS : 3.5100 (+2.63%)
CTXS : 108.25 (-0.45%)
PCOM : 9.80 (-0.71%)
HTHT : 31.16 (-10.79%)
MAN : 73.13 (-1.76%)
CNK : 39.56 (-3.32%)
AMAT : 34.44 (-3.56%)
FMCC : 2.5100 (+5.46%)
MRK : 75.83 (-0.05%)
ATOS : 1.38 (+2.99%)
WTCRF : 0.0138 (unch)
MLRKF : 0.0835 (-6.07%)
GAZ-UN.VN : 0.600 (unch)
MEOH : 55.91 (-5.17%)
COOL : 17.33 (-0.69%)
SAVE : 58.06 (-2.19%)
PCRX : 40.46 (+1.05%)
RNLSY : 12.7650 (-1.47%)
COL : 141.04 (-0.42%)
COR : 93.21 (-1.15%)
IDXG : 1.03 (-4.63%)
MCD : 184.57 (+1.10%)
ETST : 0.8500 (+19.72%)
QNIIF : 0.7100 (-2.62%)
PII : 85.45 (-3.25%)
AMRS : 3.44 (-4.18%)
SON : 54.85 (+0.07%)
MCK : 125.87 (-0.63%)
APHA : 7.08 (+5.99%)
MCO : 155.48 (-2.46%)
GSKY : 11.00 (-0.09%)
LH : 135.70 (-1.45%)
SAP.TO : 38.67 (-1.60%)
ODFL : 132.90 (-2.73%)
NEU : 401.66 (+0.28%)
ORTX : 12.90 (-3.15%)
BXE.TO : 0.55 (-3.51%)
GWPRF : 11.8700 (+6.23%)
PZN : 8.49 (-3.41%)
RBX.VN : 0.075 (unch)
RNG : 88.78 (-2.71%)
SPG : 173.26 (-0.40%)
TRVN : 0.53 (-3.45%)
AMC : 13.51 (-6.57%)
UTX : 111.06 (-2.49%)
AMD : 19.76 (-4.86%)
NDLS : 7.45 (-1.46%)
MPWR : 120.98 (-3.04%)
KGKG : 0.0580 (+3.94%)
FRO-UN.VN : 0.550 (unch)
DMCAF : 0.2660 (-5.10%)
IRMTF : 11.9721 (-0.40%)
BOX : 19.45 (-2.16%)
IQST : 2.5000 (+25.00%)
ASPS : 23.23 (-2.72%)
HMNY : 0.01 (unch)
ROP : 274.70 (-2.60%)
GOVB : 14.5000 (unch)
PKO : 25.55 (-1.01%)
MYGN : 28.89 (-2.63%)
CRL : 117.59 (-1.36%)
GLPH : 0.0220 (-12.00%)
BXXRF : 0.0051 (-74.50%)
ADTN : 11.78 (-0.93%)
GRNH : 0.0200 (unch)
NS : 25.65 (-2.77%)
LTS : 2.99 (-3.55%)
INT : 23.97 (-1.36%)
INPX : 2.28 (+2.24%)
GSPT : 0.0600 (-50.00%)
MRO.VN : 0.110 (+10.00%)
COST : 212.40 (-0.56%)
EFX : 103.62 (-0.59%)
BMRN : 95.66 (-2.08%)
SPGI : 187.29 (-0.72%)
IGCC : 0.3940 (+3.41%)
PYPL : 89.94 (-1.29%)
LHSIF : 0.7526 (-0.97%)
TDY : 217.39 (-3.44%)
AZPN : 88.93 (-2.24%)
ENW.VN : 1.410 (+2.92%)
DMA.VN : 4.630 (-2.11%)
SNAP : 5.93 (-4.05%)
KSU : 108.45 (-1.87%)
MERC : 14.61 (-1.08%)
DVA : 56.85 (-0.91%)
UNI.VN : 3.700 (-0.27%)
MGI : 2.21 (+0.45%)
IGAP : 0.2310 (-57.92%)
FIT : 6.06 (+0.17%)
RAD : 0.94 (-3.51%)
LDSR : 0.0042 (+7.69%)
CYLYF : 0.1108 (+14.23%)
PMX : 11.38 (-1.04%)
ROBXF : 0.1851 (+262.94%)
BRO : 28.32 (-1.12%)
OncBioMune Phase 2 Clinical Trial to Begin Enrollment; Company Announces Other Developments and Corporate Milestones

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary therapeutic cancer vaccine immunotherapy...

OBMP : 0.0103 (-6.36%)
OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary therapeutic cancer vaccine immunotherapy...

OBMP : 0.0103 (-6.36%)
OncBioMune Advancing ProscaVax Towards Second Phase 2 Clinical Trial for Prostate Cancer with Protocol Submission to FDA

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology...

OBMP : 0.0103 (-6.36%)
OncBioMune Returns Protocol to Scientific Review Committee Overseeing Phase 2 Prostate Cancer Clinical Trial

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology...

OBMP : 0.0103 (-6.36%)
Scientific Review Committee Meets on OncBioMune's Phase 2 Prostate Cancer Clinical Trial

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology...

OBMP : 0.0103 (-6.36%)
OncBioMune Announces Presentation at the 2018 AACR Annual Meeting

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology...

OBMP : 0.0103 (-6.36%)
OncBioMune Appoints Robert Neal Holcomb to Board of Directors

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary immunotherapy cancer vaccine technology...

OBMP : 0.0103 (-6.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade OBMP with:

Key Turning Points

2nd Resistance Point 0.0119
1st Resistance Point 0.0111
Last Price 0.0103
1st Support Level 0.0099
2nd Support Level 0.0095

See More

52-Week High 0.0450
Fibonacci 61.8% 0.0312
Fibonacci 50% 0.0270
Fibonacci 38.2% 0.0227
Last Price 0.0103
52-Week Low 0.0089

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar